FDA Inspection 1150636 — Susannah K. Eyre, M.D.
The FDA completed an inspection of Susannah K. Eyre, M.D. on August 13, 2021 in Liverpool. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 13, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Liverpool (United Kingdom)
Additional Details
Clinical Investigator (CI)